Table 1.
The prevalence of T2D across different levels of PA and sleep duration between 2011 and 2020
| LPA | MPA | VPA | Short sleep | Normal sleep | Long sleep | ||
|---|---|---|---|---|---|---|---|
| 2011 | Events/n | 63 | 169 | 432 | 190 | 422 | 52 |
|
Prevalence (95% CI) |
13.35% (10.41–16.75) |
12.88% (11.11–14.81) |
10.93% (9.97–11.94) |
11.52% (10.01–13.15) |
11.58% (10.56–12.66) |
11.76% (8.91–15.14) |
|
| 2013 | Events/n | 34 | 125 | 173 | 103 | 201 | 28 |
|
Prevalence (95% CI) |
8.52% (5.97–11.70) |
9.54% (8.01–11.26) |
5.33% (4.58–6.16) |
6.56% (5.38–7.90) |
6.63% (5.77–7.58) |
7.93% (5.33–11.26) |
|
| 2015 | Events/n | 93 | 330 | 708 | 356 | 674 | 101 |
|
Prevalence (95% CI) |
19.42% (15.97–23.25) |
19.35% (17.50-21.31) |
15.27% (14.24–16.33) |
16.85% (15.28–18.51) |
16.61% (15.47–17.78) |
15.59% (12.87–18.61) |
|
| 2018 | Events/n | 167 | 810 | 1243 | 837 | 1183 | 200 |
|
Prevalence (95% CI) |
13.96% (12.05–16.06) |
16.40% (15.37–17.46) |
10.96% (10.39–11.55) |
14.37% (13.48–15.29) |
11.74% (11.11–12.38) |
12.71% (11.10-14.45) |
|
| 2020 | Events/n | 192 | 876 | 1382 | 950 | 1337 | 163 |
|
Prevalence (95% CI) |
17.27% (15.09–19.62) |
17.47% (16.42–18.55) |
13.03% (12.39–13.68) |
16.28% (15.34–17.25) |
13.73% (13.05–14.43) |
14.06% (12.11–16.20) |
|
| Total | Events/n | 549 | 2310 | 3938 | 2436 | 3817 | 544 |
|
Prevalence (95% CI) |
15.01% (13.88–16.18) |
16.17% (15.57–16.79) |
11.66% (11.32–12.01) |
14.33% (13.77–14.91) |
12.49% (12.14–12.84) |
13.03% (12.06–14.05) |
|
| Trends | P for trends | p < 0.05 | p < 0.001 | p < 0.001 | p < 0.001 | p < 0.001 | p < 0.001 |
Abbreviations 95% CI = 95% confidence interval; LPA = light-volume physical activity; MPA = moderate-volume physical activity; VPA = vigorous-volume physical activity